Cardinal Health buys Strive Medical and AdaptHealth diabetes unit for $360m
Cardinal Health is spending $360 million to acquire a urology supplier and a diabetes business, accelerating its push into the direct-to-patient home care market.
Cardinal Health has acquired urology-focused medical supplier Strive Medical and AdaptHealth’s diabetes business for a combined $360 million. The dual purchases mark the latest step in the Ohio-based distributor’s strategy to build out its at-home medical solutions network.
The deals indicate Cardinal is prioritizing the direct-to-patient market. The company supplies medical equipment directly to consumers and supports hospital-at-home programmes across the US.
The AdaptHealth transaction directly extends Cardinal’s footprint in diabetes management. It follows the company’s April 2025 purchase of Advanced Diabetes Supply (ADS). The integration of ADS has already yielded measurable operational results, including migrating all ADS volume onto the home care distribution network and onboarding nearly 500,000 new customers.
As part of that integration, the company launched ContinuCare Pathway, a digital referral programme connecting pharmacies directly with suppliers. This infrastructure positions Cardinal to efficiently absorb the newly acquired AdaptHealth diabetes unit.
On the urology side, the Strive Medical purchase caps a months-long consolidation effort. Cardinal acquired Solaris Health for $1.9 billion in August 2025, alongside Academic Urology & Urogynecology in the same month. It also picked up Urology America and Potomac Urology in April 2025.
This string of acquisitions demonstrates a clear playbook. Cardinal is buying niche providers to achieve national scale in specific therapeutic categories.
"These strategic transactions build on the synergies created by our recent investments in home care," CEO Jason Hollar said. "As a natural extension of our at-home solutions growth strategy, they expand our enterprise-wide depth and breadth across important therapeutic categories like diabetes management and urology, further strengthening our leadership in a highly dynamic industry," Hollar continued.
The operational groundwork laid in the current fiscal year sets the stage for further expansion. "Our significant operational achievements in FY26 position us to continue building the country's leading platform to deliver simplified, innovative and high-quality care in the home, both organically and through acquisition," said Rob Schlissberg, president of the at-home solutions business.
